Skip to Content
Merck
CN
  • Identification of a pharmacophore for thrombopoietic activity of small, non-peptidyl molecules. 1. Discovery and optimization of salicylaldehyde thiosemicarbazone thrombopoietin mimics.

Identification of a pharmacophore for thrombopoietic activity of small, non-peptidyl molecules. 1. Discovery and optimization of salicylaldehyde thiosemicarbazone thrombopoietin mimics.

Journal of medicinal chemistry (2002-08-09)
Kevin J Duffy, Anthony N Shaw, Evelyne Delorme, Susan B Dillon, Connie Erickson-Miller, Leslie Giampa, Yifang Huang, Richard M Keenan, Peter Lamb, Nannan Liu, Stephen G Miller, Alan T Price, Jon Rosen, Heather Smith, Kenneth J Wiggall, Lihua Zhang, Juan I Luengo
PMID12166928
ABSTRACT

High-throughput screening has resulted in the discovery of thiosemicarbazone thrombopoietin mimics. A shared pharmacophore hypothesis between this series and a previously identified class, the pyrazol-4-ylidenehydrazines, led to the rapid optimization of both potency and efficacy of the thiosemicarbazones. The application of high-throughput chemistry and purification techniques allowed for the rapid elucidation of structure-activity relationships.